Advanced Biomed Inc. (ADVB) Form 10-K Annual Reports
Advanced Biomed Inc. (ADVB) is a publicly traded company on the Nasdaq, categorized under SIC 8071 (Services-Medical Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ADVB
CIK: 1941029
Exchange: Nasdaq
SIC 8071: Services-Medical Laboratories
Fiscal Year End: 06/30
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WWC, P.C.
Auditor SinceSince 6/30/2022 12:00:00 AM
Lead Engagement PartnerPatrick Wong
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-K | 2026-10-13 | 2026-06-30 | ANNUAL REPORT | 0001213900-26-109029 | View SEC Doc Filr Page |
| NT 10-K | 2026-09-28 | 2026-06-30 | NT 10-K | 0001213900-26-104071 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-22 | — | SCHEDULE 13G Filing | 0002155122-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-07-27 | 4 Filing | 0001079973-26-001162 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-20 | — | SCHEDULE 13G/A Filing | 0001079973-26-001160 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-20 | — | SCHEDULE 13G Filing | 0001079973-26-001158 | View SEC Doc Filr Page |
| RW | 2026-07-20 | — | WITHDRAWAL REQUEST | 0001213900-26-079677 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-14 | CURRENT REPORT | 0001213900-26-079233 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-06-30 | CURRENT REPORT | 0001213900-26-074306 | View SEC Doc Filr Page |
| 8-K | 2026-06-30 | 2026-06-30 | CURRENT REPORT | 0001213900-26-073735 | View SEC Doc Filr Page |
| DEF 14A | 2026-06-04 | 2026-06-30 | DEFINITIVE PROXY STATEMENT | 0001213900-26-065017 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-057226 | View SEC Doc Filr Page |
| 8-K | 2026-05-01 | 2026-04-28 | CURRENT REPORT | 0001213900-26-051028 | View SEC Doc Filr Page |
| 8-K | 2026-04-14 | 2026-04-13 | CURRENT REPORT | 0001213900-26-043557 | View SEC Doc Filr Page |
| 8-K | 2026-04-03 | 2026-04-02 | CURRENT REPORT | 0001213900-26-040030 | View SEC Doc Filr Page |
| 8-K | 2026-03-30 | 2026-03-25 | CURRENT REPORT | 0001213900-26-036424 | View SEC Doc Filr Page |
| 8-K | 2026-03-16 | 2026-03-12 | CURRENT REPORT | 0001213900-26-028330 | View SEC Doc Filr Page |
| 8-K | 2026-02-26 | 2026-02-20 | CURRENT REPORT | 0001213900-26-020807 | View SEC Doc Filr Page |
| 10-Q | 2026-02-13 | 2025-12-31 | QUARTERLY REPORT | 0001213900-26-016458 | View SEC Doc Filr Page |
| 8-K/A | 2026-02-10 | 2025-06-06 | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-26-014247 | View SEC Doc Filr Page |
| 8-K | 2026-02-02 | 2026-01-28 | CURRENT REPORT | 0001213900-26-010809 | View SEC Doc Filr Page |
| 8-K | 2026-01-27 | 2026-01-26 | CURRENT REPORT | 0001213900-26-008254 | View SEC Doc Filr Page |
| DEF 14C | 2026-01-23 | 2026-01-23 | DEFINITIVE INFORMATION STATEMENT | 0001213900-26-007188 | View SEC Doc Filr Page |
| 8-K | 2026-01-21 | 2026-01-16 | CURRENT REPORT | 0001213900-26-006281 | View SEC Doc Filr Page |
| PRE 14C | 2026-01-12 | 2026-01-12 | PRELIMINARY INFORMATION STATEMENT | 0001213900-26-003378 | View SEC Doc Filr Page |